We are looking for a Sales Manager Europe to help us meet our customer acquisition and revenue growth targets by keeping our company competitive and innovative. You will be responsible for maximizing sales potential, managing existing customers, and acquiring new ones. The company is new and the product is very innovative, the salary will [...]
About Giulia PiaggioThis author has not yet filled in any details.
So far Giulia Piaggio has created 72 blog entries.
In this recent scientific result, our team demonstrates that the in vivo-like dynamic environment provided by the MIVO® device allows for better modeling of the 3D tumor environment and predicting drug efficacy in vivo compared to a static in vitro model. Scheme of the in vitro 3D human cancer culture within MIVO® chamber under [...]
MIVO® and intestinal permeability, a perfect combination to study the absorption mechanism and the biological effects of drugs and food compoundsGiulia Piaggio2020-08-27T13:22:02+00:00
MIVO® technology has made possible the implementation of a fluidic 3D in vitro model of the intestinal barrier. In this article it is demonstrated that MIVO®, combined with a 3D intestinal epithelium model, allows to emulate the intestinal environment in vitro, as a reliable platform for the study of the passage of molecules, discriminating [...]
Polyglot, bioengineer, pianist and a few weeks ago React4lifer! We introduce Livia who is doing a stage in our R&D district in Vimodrone Livia, tell us about yourself I am an Italian girl, born and raised in Brussels and I am currently studying Biomedical Engineering at Imperial College London. Overall, I am a creative [...]
3D Human Cancer Models with MIVO and Culturing 3D Tissues: we talk about it today at the Drug Discovery summitGiulia Piaggio2020-07-30T08:03:05+00:00
"A Biology-Driven Multi-Chamber Device For Culturing 3D Tissues And Performing Reliable Absorption Assays" and "3D Human Cancer Models Within The MIVO- Multi In Vitro Organ Fluidic Device For Improving The Outcome Of In Vitro Drug Testing" are the titles of our poster on Oxofrod Global today. We are proud to be here to present [...]
Monzino and Spallanzani, with the biotech React4life, join forces to study new therapies to protect the heart from the virus. Regione Lombardia finances the Cardio-Cov research project. To understand the mechanisms on the heart connected to COVID-19, Centro Cardiologico Monzino, with the collaboration of the National Institute of Infectious Diseases (INMI) "Lazzaro Spallanzani" in [...]
At the European Organ-On-Chip Society meeting we will present: “3D Human Tissues Within The MIVO-Multi In Vitro Organ Fluidic Device for Improving The Outcome Of In Vitro Drug Testing Assays” to demonstrate how the MIVO® platform combined with 3D human tissues can they represent a novel, highly reliable and easy to use in vitro [...]
For the third straight year, the European Innovation Council has organized the EIC Corporate Days, gathering innovative European SMEs and large corporates to take full advantage of partnering opportunities. This year, the pharmaceutical giant ROCHE was also invited to meet EIC-funded SMEs and participate in the EIC Corporate Day initiative. From 22 till 25 June 2020, [...]
What we really know about drug tests: advantages and disadvantages of 3R methods and animal tests. The principles of 3R (replacement, reduction and refinement) were developed over 50 years ago to conduct research on more human animals. Biomedical research requires continuous updating on solid experimental models and in this scenario 3R-based approaches can become [...]
Our Absorption test is the innovative solution to the EU regulation 2017/745 relating to medical devicesGiulia Piaggio2020-05-29T11:54:55+00:00
Due to the health emergency of Covid19, on Thursday 23 April 2020 the European Council approved and formalized the one-year extension of the 2017/745 Regulation on medical devices, postponing their application until 26 May 2021 (https://data.consilium.europa.eu/doc/document/ST-7180-2020-INIT/en/pdf). What research areas are involved, and what it foresees this legislation, for a specific type of device, we [...]